Vienna, Austria, December 25th, 2025, ChainwireHoneyBadger BFT (HBBFT) consensus, which has been successfully pioneered and ...
The DMD/MBA program is an integrative, four-year degree that combines business courses with the DMD curricula. Students start their business classes the summer before dentistry school. The remaining ...
Taiho Pharmaceutical’s investigational treatment for Duchenne muscular dystrophy (DMD) has failed to impact the time it takes patients to rise from the floor over 52 weeks, missing the phase 3 study’s ...
Scientists have developed a novel approach of genome editing to repair muscle stem (satellite) cells, offering new hope for ...
After escaping a clinical hold several years back, Dyne Therapeutics has revealed new phase 1/2 data for its Duchenne muscular dystrophy (DMD) therapy DYNE-251. The readout notes several serious ...
Duchenne muscular dystrophy (DMD) occurs as a result of genetic changes on the X chromosome. If someone has a gene change that can cause DMD, their children may inherit that change. DMD is a ...
This rare genetic disorder is due to the absence of a vital protein called dystrophin that helps the body maintain muscle cells, which results in rapid muscle degeneration and increasing muscle ...
Duchenne muscular dystrophy (DMD) is a condition that makes muscles weaker over time, specifically those you use to move, breathe, and those that help your heart function. It's caused by flaws in the ...
Sarepta Therapeutics said it will update its prescribing information for Elevidys ® (delandistrogene moxeparvovec-rokl) after acknowledging the sudden death of a patient with Duchenne muscular ...
Sarepta Therapeutics has temporarily suspended use of the gene therapy Elevidys in non-ambulatory patients with Duchenne muscular dystrophy (DMD) after a second patient taking the drug died from acute ...
Eteplirsen may delay cardiac deterioration in DMD patients by reducing the risk of reaching LVEF decline thresholds. None of the eteplirsen-treated patients reached an LVEF below 50%, compared to 22.1 ...